Navigation Links
iTech Medical Provides Update on MPR Clinical Development Plan
Date:10/1/2009

HUNTINGTON BEACH, Calif., Oct. 1 /PRNewswire-FirstCall/ -- iTech Medical, Inc. (OTC Bulletin Board: IMSU; FWB: 0IM), a medical information technology company, today provided an update on the Company's clinical and regulatory plans for its proprietary Muscle Pattern Recognition (MPR) System. MPR is a patented clinical tool that analyzes patterns of muscle recruitment. MPR provides detailed physiological information on muscle function that can assist in the diagnosis and treatment of back and neck injuries and illness.

iTech Medical is currently conducting a clinical trial of the MPR System at the Utah Spine and Joint Center in Salt Lake City, Utah. The trial began in February 2009 and to date, the Company has completed testing on more than 250 study subjects, many with chronic back pain. The Company stated that patient recruitment for the balance of the trial is being shifted to test subjects with recent, acute back injuries to allow for a more rigorous testing of the MPR data analysis system.

"The results of the clinical trial to date are very encouraging and we look forward to completing the study in the early part of 2010," stated Dr. Alan Goldman, Vice President, Clinical and Medical Affairs at iTech Medical. "Following the trial, we plan to submit our results to the FDA and to several peer-review journals for publication."

The Company also reported that it expects to begin a randomized, multi-centered clinical trial of the MPR System following the completion of the current trial. "The goal of this second clinical trial will be to independently demonstrate the capacity of MPR testing to objectively determine patient progress and outcomes," said Dr. Goldman. "We believe that the MPR evaluation modality will allow a physician, for the first time, to objectively identify and quantify the specific underlying physiologica
'/>"/>

SOURCE iTech Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. iTech Medical to Present at BioContact Qubec 2009
2. Amitech Solutions Selected to Implement SharePoint Portal for BlueAdvantage Administrators of Arkansas
3. HCCA Web Conference Addresses Health Information Security & Data Breach Under HITECH Act, September 17, 2009, 12 Noon Central
4. Consulting and Advisory Firm Specializing in Data Security Helps Health Care Organizations Comply with New Breach Notification Rules Concerning Encryption in HITECH ACT, within ARRA
5. Healthcare Informatics Associates, an InfoLogix Company, Selected by Hilo Medical Center for MEDITECH 6.0 EMR Implementation
6. ID Experts Offers Breach Prevent for Healthcare: A High-Touch, Affordable Solution for HITECH Data Breach Protection and Compliance
7. New SAFC Hitech(R) Product Roadmap Plots Route for Future Generation Semiconductor Materials
8. Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry
9. Golden Meditech Announces Financial Year 2008/09 Annual Results
10. Accumetrics, Inc. Announces United Kingdom Distribution Agreement With ELITech UK Limited
11. Sensitech Announces Green Solutions Recycling Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 TheCelebrityDresses.com, a popular ... big discounts on their summer fashion cocktail dresses. The ... short dresses that would be suitable for a wide ... , TheCelebrityDresses.com designs and make high quality trendy ... they use include high quality satin, chiffon and cotton. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 The ... a study from the RSSearch® Patient Registry evaluating ... body radiotherapy (SBRT) for the treatment of centrally ... lung metastases. , The study, published in ... http://www.ro-journal.com/content/10/1/113/abstract ), included 111 patients with 114 centrally ...
(Date:6/2/2015)... Robert LaPrade, MD, PhD, Colorado Knee ... Research Institute, participated in the study “ When ... This was a collaborative project from the American Orthopaedic ... recently published in the American Journal of Sports Medicine. ... is evidence that early sport specialization may put young ...
(Date:6/2/2015)... Each year, Cosmetic Executive Women (CEW) awards ... year, the organization’s members – 8,000 industry experts – ... Beauty Quest Award at the 2015 Beauty Insiders’ Choice ... and 2-in-1 approach to skincare differentiated it amongst a ... consumer and professional fan bases, QVC has awarded Scalisi ...
(Date:6/2/2015)... 2015 SB 277 (CA Legislature, bit.ly/1Q0P8OY) ... to attend public or private school. SB277 cleared three ... the Appropriations Committee (Sacramento Bee, May 11, 2015, bit.ly/1Gh9jU7). ... , “We believe that this bill affects the ... than it will (the) affect public health of California.. ...
Breaking Medicine News(10 mins):Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 2Health News:New Study from RSSearch® Patient Registry Highlights Treatment Patterns and Clinical Outcomes of Stereotactic Radiosurgery for Central Lung Tumors 3Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 2Health News:Early Single Sport Specialization May Put Youth Athletes at Risk for Overuse Injuries According to Colorado Knee Specialist Robert LaPrade, MD, PhD 3Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2
... 8 /Xinhua-PRNewswire-FirstCall/ -- China Sky One,Medical, Inc. (OTC ... pharmaceutical, medicinal and diagnostic products in China,today announced ... to,the Company,s Form 10KSB for the year 2006. ... Form 10QSB for the three, six and nine ...
... COMPANY REPORTS PROGRESS ON KEY INITIATIVES, RANCHO CORDOVA, ... a leading supplier of innovative products and,services that process, ... treatment of disease and injury, today reported results for,the ... quarter ended September 30, 2007, were $3.6 million,compared with ...
... OWINGS MILLS, Md., Nov. 8 Medifast, Inc.,(NYSE: ... the period ended,September 30, 2007. For quarter-ended September 30, ... from $19.6 million in the third,quarter of 2006. The ... share ($0.07 per diluted share), versus $1,455,000 or $0.11 ...
... ESAs can increase cancer growth, cause stroke and heart ... News) -- The U.S. Food and Drug Administration on ... erythropoiesis-stimulating agents, which are drugs used to treat certain ... Aranesp, Epogen and Procrit, and detail their dangers to ...
... N.J., Nov. 8 Wyeth (NYSE: WYE ),announced ... First Boston,Healthcare Conference on Tuesday, November 13, 2007 at ... M. Mahady, Senior Vice President,Wyeth and President, Wyeth Pharmaceuticals ... for investors at, http://www.wyeth.com and available for replay ...
... CLEVELAND, Nov. 8 Medical Mutual and Ohio ... to provide quality,affordable health insurance to OFBF,s more ... Farm Bureau members will gain access to,Medical Mutual,s ... hospitals and other medical service providers in Ohio. ...
Cached Medicine News:Health News:China Sky One Medical Completes Previously Announced Amendment to 2006 Form 10KSB 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 4Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 5Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 6Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 2Health News:Medifast Announces Third-Quarter 2007 Results 3Health News:Medifast Announces Third-Quarter 2007 Results 4Health News:Medifast Announces Third-Quarter 2007 Results 5Health News:Medifast Announces Third-Quarter 2007 Results 6Health News:Medifast Announces Third-Quarter 2007 Results 7Health News:Medifast Announces Third-Quarter 2007 Results 8Health News:FDA Issues New Warnings for Anemia Drugs 2Health News:FDA Issues New Warnings for Anemia Drugs 3Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 2Health News:Ohio Farm Bureau Health Plan Awarded to Medical Mutual of Ohio 3
(Date:6/1/2015)... DUBLIN , June 1, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/qrmgrq/_analysis_of_the ) has announced the addition of ... Image Displays Market" report to their ... ,This report provides an in-depth analysis of ... revenue forecast, market shares, market dynamics, and ...
(Date:6/1/2015)... -- Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data ... in a Phase 1 investigator-sponsored study at the University ... presented at the 2015 American Society of Clinical Oncology ... Results from this study show a tolerable safety ... given intravenously.  Based in part on the ...
(Date:6/1/2015)... June 1, 2015 The Middle Eastern MRI systems ... which is replacing CT because of its higher sensitivity and ... one between the two available systems of MRI, open and ... top and bottom and do not enclose the patient in ... a study which shows that one in every 6 patients ...
Breaking Medicine Technology:Analysis of the US Medical Image Displays Market 2015-2017 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5Middle East Open System MRI Market - Growth, Trends And Forecasts (2014 - 2019) 2
... the,symptoms of thyroid disease for another disorder such ... a new edition of a report from,Harvard Medical ... particularly in older men and women, that doctors ... focus on common,illnesses that occur with age, according ...
... /Xinhua-PRNewswire/ -- TaiGen Biotechnology,Inc. announces the successful completion ... clinical trial of Nemonoxacin (TG-873870) for,the treatment of ... have been admitted to the trial. Completion of ... quarter of 2007. In this trial, the effect,of ...
Cached Medicine Technology:You May Have a Thyroid Problem and Not Know It - Particularly If You're Over 60, Says a New Harvard Medical School Report 2TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP) 2
All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheostat for fine control of il...
Pocket-sized instrument. All Keeler otoscopes have bright halogen illumination for clear and accurate visualization of aural canal. Lithium-ion batteries with quick recharge capability. Ring rheos...
Pocket-sized instrument with fiber optic illumination. Swivelling viewing window with 3X magnification....
All metal construction with fiber optic illumination. Large diameter viewing port, insufflation port, and swivelling airtight window....
Medicine Products: